These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9098400)

  • 61. No excess of DR*3/4 in Ashkenazi Jewish or Hispanic IDDM patients.
    Rubinstein P; Walker M; Mollen N; Carpenter C; Beckerman S; Suciu-Foca N; McEvoy R; Ginsberg-Fellner F
    Diabetes; 1990 Sep; 39(9):1138-43. PubMed ID: 2384193
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
    Carrier CM; Mollen N; Rothman WC; Rodriguez de Cordoba S; Rey-Campos J; Ginsberg-Fellner F; Carpenter C; Rubinstein P
    Hum Immunol; 1989 Jan; 24(1):51-63. PubMed ID: 2563360
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DQA1 restriction fragment length polymorphisms and insulin-dependent diabetes mellitus: a BglII fragment labels a subset of B8,DR3 haplotypes uniquely associated with insulin-dependent diabetes mellitus.
    Carrier C; Mollen N; Ginsberg-Fellner F; Rothman WC; Rubinstein P
    Hum Immunol; 1989 Dec; 26(4):344-52. PubMed ID: 2573591
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Bgl II RFLP associated with type 1 diabetes in DR3-positive subjects is not due to a DQA1 promoter region polymorphism.
    Cavan DA; Kelly MA; Jacobs KH; Penny MA; Jenkins D; Mijovic C; Barnett AH
    Autoimmunity; 1994; 17(2):123-5. PubMed ID: 7914753
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. The "Childhood Diabetes in Finland" (DiMe) Study Group.
    Reijonen H; Ilonen J; Akerblom HK; Knip M; Dosch HM
    Tissue Antigens; 1994 Jan; 43(1):1-6. PubMed ID: 7912856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
    Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monocyte function in IDDM patients and healthy individuals.
    Mølvig J; Pociot F; Baek L; Worsaae H; Dall Wogensen L; Christensen P; Staub-Nielsen L; Mandrup-Poulsen T; Manogue K; Nerup J
    Scand J Immunol; 1990 Sep; 32(3):297-311. PubMed ID: 1698309
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Skewed T-cell receptor usage and junctional heterogeneity among isletitis alpha beta and gamma delta T-cells in human IDDM [corrected].
    Santamaria P; Lewis C; Jessurun J; Sutherland DE; Barbosa JJ
    Diabetes; 1994 Apr; 43(4):599-606. PubMed ID: 8024653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-HLA region genes in insulin dependent diabetes mellitus.
    Field LL
    Baillieres Clin Endocrinol Metab; 1991 Sep; 5(3):413-38. PubMed ID: 1909861
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls.
    Kockum I; Sanjeevi CB; Eastman S; Landin-Olsson M; Dahlquist G; Lernmark A
    Eur J Immunogenet; 1995 Dec; 22(6):443-65. PubMed ID: 8597561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.
    Nepom BS; Palmer J; Kim SJ; Hansen JA; Holbeck SL; Nepom GT
    J Exp Med; 1986 Jul; 164(1):345-50. PubMed ID: 3014039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.
    Thomsen M; Mølvig J; Zerbib A; de Preval C; Abbal M; Dugoujon JM; Ohayon E; Svejgaard A; Cambon-Thomsen A; Nerup J
    Immunogenetics; 1988; 28(5):320-7. PubMed ID: 3139557
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An increased risk of insulin-dependent diabetes mellitus (IDDM) among HLA-DR4,DQw8/DRw8,DQw4 heterozygotes.
    Rønningen KS; Markussen G; Iwe T; Thorsby E
    Hum Immunol; 1989 Mar; 24(3):165-73. PubMed ID: 2564383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
    Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
    Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genes predisposing to IDDM in multiplex families.
    Field LL
    Genet Epidemiol; 1989; 6(1):101-6. PubMed ID: 2499498
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Speculation on the evolution of insulin-dependent diabetes genes.
    MacDonald MJ
    Metabolism; 1988 Dec; 37(12):1182-4. PubMed ID: 3264044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple sclerosis susceptibility: population and twin study of polymorphisms in the T-cell receptor beta and gamma genes region. French Group on Multiple Sclerosis.
    Briant L; Avoustin P; Clayton J; McDermott M; Clanet M; Cambon-Thomsen A
    Autoimmunity; 1993; 15(1):67-73. PubMed ID: 8105988
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Testing parental imprinting in insulin-dependent diabetes mellitus by the marker-association-segregation-chi 2 method.
    Margaritte-Jeannin P; Clerget-Darpoux F; Hors J; Deschamps I
    Am J Hum Genet; 1995 May; 56(5):1080-7. PubMed ID: 7726162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.